These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens. Watt B; Naden MG Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937 [TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg. van der Westhuyzen I; Chalkley LJ S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria. Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712 [TBL] [Abstract][Full Text] [Related]
25. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics. Schaumann R; Funke M; Janssen E; Rodloff AC Antimicrob Agents Chemother; 2012 Jun; 56(6):3413-6. PubMed ID: 22430962 [TBL] [Abstract][Full Text] [Related]
26. [Sensitivity of anaerobes to 8 antibiotics]. Sedallian A Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760 [TBL] [Abstract][Full Text] [Related]
27. Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis. Ferreira MC; Domingues RM; de Uzeda M J Antimicrob Chemother; 1989 Aug; 24(2):157-64. PubMed ID: 2793640 [TBL] [Abstract][Full Text] [Related]
28. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Schaumann R; Petzold S; Fille M; Rodloff AC Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869 [TBL] [Abstract][Full Text] [Related]
29. Resistance to chloramphenicol and metronidazole in anaerobic bacteria. Britz ML J Antimicrob Chemother; 1981 Dec; 8 Suppl D():49-57. PubMed ID: 6279556 [No Abstract] [Full Text] [Related]
30. Susceptibility of New Zealand isolates to anaerobic bacteria to tinidazole. Tannock GW N Z Med J; 1979 Aug; 90(642):149-50. PubMed ID: 290923 [TBL] [Abstract][Full Text] [Related]
31. Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection. Lewis RE; Klepser ME; Ernst EJ; Snabes MA; Jones RN Diagn Microbiol Infect Dis; 2000 May; 37(1):51-5. PubMed ID: 10794941 [TBL] [Abstract][Full Text] [Related]
32. Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Ralph ED; Kirby WM Antimicrob Agents Chemother; 1975 Oct; 8(4):409-14. PubMed ID: 172007 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group. Jokipii L; Jokipii AM Antimicrob Agents Chemother; 1985 Oct; 28(4):561-4. PubMed ID: 4073879 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983. Nord CE; Olsson-Liljequist B Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139 [TBL] [Abstract][Full Text] [Related]
35. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole. Soriano F; Ponte MC; Gaspar MC J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209 [TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria. Wüst J; Hardegger U Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894 [TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron. Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Wust J Antimicrob Agents Chemother; 1977 Apr; 11(4):631-7. PubMed ID: 856015 [TBL] [Abstract][Full Text] [Related]
39. The in-vitro activity of metronidazole against Enterobacteriaceae alone and in mixed cultures with Bacteroides fragilis. Moran FJ; Perez C; Hurtado C; Blanco MT; Prieto J J Antimicrob Chemother; 1987 Nov; 20(5):657-61. PubMed ID: 3429370 [TBL] [Abstract][Full Text] [Related]
40. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study]. Grollier G; Mory F; Quentin C; Girard-Pipau F; Tigaud S; Sedallian A; Dubreuil L Pathol Biol (Paris); 1994 May; 42(5):498-504. PubMed ID: 7824321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]